Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.63 |
| ▸ | PTGES | O14684 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 8/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 6/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27188360 | 0.90 | PPARG (0.63) | PPARGPTGESRAB9AHDAC1HDAC8 | |
| SCHEMBL30782720 | 0.87 | PPARG (0.56) | PPARGPTGESRAB9AHDAC1HDAC8 | |
| SCHEMBL27188276 | 0.79 | PPARG (1.00) | PPARGPTGESSMN1; SMN2 | |
| SCHEMBL29327658 | 0.78 | PPARG (0.52) | PPARGPTGESRAB9AHDAC1HDAC8 | |
| SCHEMBL30782719 | 0.78 | PPARG (0.56) | PPARGPTGESRAB9ANPC1PTGDR2 | |
| SCHEMBL29327609 | 0.78 | PPARG (0.55) | PPARGPTGESRAB9ACYP1A2CYP2C19 | |
| SCHEMBL27188343 | 0.78 | NPC1 (0.53) | PPARGRAB9AHDAC1HDAC8HDAC6 | |
| SCHEMBL27188330 | 0.78 | KDM4E (0.57) | PPARGRAB9AHDAC1HDAC8HDAC6 | |
| SCHEMBL31721000 | 0.78 | NAMPT (0.67) | RAB9AHDAC1HDAC8HDAC6NPC1 | |
| SCHEMBL26603187 | 0.78 | NAMPT (0.67) | RAB9AHDAC1HDAC8HDAC6NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109850-A1 | Covalent PPARG inverse-agonists | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109850-A1 | Covalent PPARG inverse-agonists | PPARG, PPARD, PPARA | PPARG 1/4885PTGES 182/4885RAB9A 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.